Skip to Content
 

News: Clinical Trials

Urologic cancer expert Rini joins VICC as chief of Clinical Trials

Thursday, October 24th, 2019

Brian Rini, MD, an internationally recognized leader in genitourinary oncology, kidney cancer, and clinical drug development, is joining Vanderbilt-Ingram Cancer Center as the inaugural chief of Clinical Trials.

Study examines pain processing in co-occurring cancer, Alzheimer’s disease

Thursday, October 10th, 2019

A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Vanderbilt surgeons lead nation in study to restore sensation in breast tissue

Friday, June 7th, 2019

Vanderbilt University Medical Center is the nation’s leading recruitment site for a new study examining the effectiveness of donor nerve grafts to restore sensation to breast tissue following mastectomy and reconstruction.

Study tests new vaccine for precancerous cervical cells

Wednesday, December 12th, 2018

Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.

Combination therapy improves small-cell lung cancer survival

Friday, October 26th, 2018

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Using light to fight GVHD

Tuesday, September 4th, 2018

Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

Berlin assumes new VICC leadership post

Thursday, May 31st, 2018

Jordan Berlin, MD, has been named associate director of Clinical Investigation Strategy and Shared Resources at Vanderbilt-Ingram Cancer Center (VICC). In his new role he will chair the Resource Allocation Committee and continue as chair of the Clinical Trials Shared Resource (CTSR) Steering Committee.

My Cancer Genome launches new search tool for clinical trials

Friday, October 27th, 2017

My Cancer Genome (MCG), a web-based cancer information tool developed by Vanderbilt-Ingram Cancer Center investigators in 2011 and supported by GenomOncology, has launched a new clinical trial search tool that allows website visitors to search for cancer clinical trials based on disease, biomarker, phase and recruiting status.

Study to test combination therapy for breast cancer

Friday, October 27th, 2017

Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

Next Page »